PortfoliosLab logo
FTXH vs. MEDI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between FTXH and MEDI is 0.53, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

FTXH vs. MEDI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Harbor Health Care ETF (MEDI). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%40.00%NovemberDecember2025FebruaryMarchApril
-1.10%
34.49%
FTXH
MEDI

Key characteristics

Sharpe Ratio

FTXH:

-0.08

MEDI:

0.12

Sortino Ratio

FTXH:

0.01

MEDI:

0.31

Omega Ratio

FTXH:

1.00

MEDI:

1.04

Calmar Ratio

FTXH:

-0.07

MEDI:

0.13

Martin Ratio

FTXH:

-0.22

MEDI:

0.37

Ulcer Index

FTXH:

5.90%

MEDI:

6.61%

Daily Std Dev

FTXH:

17.17%

MEDI:

20.38%

Max Drawdown

FTXH:

-32.11%

MEDI:

-19.24%

Current Drawdown

FTXH:

-13.16%

MEDI:

-8.31%

Returns By Period

In the year-to-date period, FTXH achieves a -5.36% return, which is significantly lower than MEDI's 4.37% return.


FTXH

YTD

-5.36%

1M

-6.75%

6M

-9.21%

1Y

-0.15%

5Y*

3.62%

10Y*

N/A

MEDI

YTD

4.37%

1M

-0.12%

6M

-3.75%

1Y

3.51%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


FTXH vs. MEDI - Expense Ratio Comparison

FTXH has a 0.60% expense ratio, which is lower than MEDI's 0.80% expense ratio.


Expense ratio chart for MEDI: current value is 0.80%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
MEDI: 0.80%
Expense ratio chart for FTXH: current value is 0.60%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
FTXH: 0.60%

Risk-Adjusted Performance

FTXH vs. MEDI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FTXH
The Risk-Adjusted Performance Rank of FTXH is 1717
Overall Rank
The Sharpe Ratio Rank of FTXH is 1717
Sharpe Ratio Rank
The Sortino Ratio Rank of FTXH is 1616
Sortino Ratio Rank
The Omega Ratio Rank of FTXH is 1616
Omega Ratio Rank
The Calmar Ratio Rank of FTXH is 1616
Calmar Ratio Rank
The Martin Ratio Rank of FTXH is 1717
Martin Ratio Rank

MEDI
The Risk-Adjusted Performance Rank of MEDI is 3131
Overall Rank
The Sharpe Ratio Rank of MEDI is 3030
Sharpe Ratio Rank
The Sortino Ratio Rank of MEDI is 3131
Sortino Ratio Rank
The Omega Ratio Rank of MEDI is 2929
Omega Ratio Rank
The Calmar Ratio Rank of MEDI is 3333
Calmar Ratio Rank
The Martin Ratio Rank of MEDI is 3030
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FTXH vs. MEDI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Harbor Health Care ETF (MEDI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for FTXH, currently valued at -0.08, compared to the broader market-1.000.001.002.003.004.00
FTXH: -0.08
MEDI: 0.12
The chart of Sortino ratio for FTXH, currently valued at 0.01, compared to the broader market-2.000.002.004.006.008.00
FTXH: 0.01
MEDI: 0.31
The chart of Omega ratio for FTXH, currently valued at 1.00, compared to the broader market0.501.001.502.002.50
FTXH: 1.00
MEDI: 1.04
The chart of Calmar ratio for FTXH, currently valued at -0.07, compared to the broader market0.002.004.006.008.0010.0012.00
FTXH: -0.07
MEDI: 0.13
The chart of Martin ratio for FTXH, currently valued at -0.22, compared to the broader market0.0020.0040.0060.00
FTXH: -0.22
MEDI: 0.37

The current FTXH Sharpe Ratio is -0.08, which is lower than the MEDI Sharpe Ratio of 0.12. The chart below compares the historical Sharpe Ratios of FTXH and MEDI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00NovemberDecember2025FebruaryMarchApril
-0.08
0.12
FTXH
MEDI

Dividends

FTXH vs. MEDI - Dividend Comparison

FTXH's dividend yield for the trailing twelve months is around 1.88%, more than MEDI's 0.52% yield.


TTM202420232022202120202019201820172016
FTXH
First Trust Nasdaq Pharmaceuticals ETF
1.88%1.66%1.56%1.10%1.03%0.82%0.67%0.92%2.18%0.19%
MEDI
Harbor Health Care ETF
0.52%0.54%1.86%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

FTXH vs. MEDI - Drawdown Comparison

The maximum FTXH drawdown since its inception was -32.11%, which is greater than MEDI's maximum drawdown of -19.24%. Use the drawdown chart below to compare losses from any high point for FTXH and MEDI. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-13.16%
-8.31%
FTXH
MEDI

Volatility

FTXH vs. MEDI - Volatility Comparison

First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Harbor Health Care ETF (MEDI) have volatilities of 11.74% and 11.43%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%NovemberDecember2025FebruaryMarchApril
11.74%
11.43%
FTXH
MEDI